|
For early stage patients who are...
UNCERTAIN OF HAVING TREATMENT PLEASE DO LOOK AT THE FOLLOWING ARTICLES FROM 2008 SABCS.
http://www.posters2view.com/sabcs08/view.php?nu=SABCS08L_269
[702] Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours. Implications for trastuzumab therapy?
http://www.posters2view.com/sabcs08/view.php?nu=SABCS08L_444
Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors.
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
|